James Abbruzzese, MD

Publications

Chang, DZ, Ma, Y, Ji, B, Wang, H, Deng, D, Liu, Y, Abbruzzese, JL, Liu, Y-J, Logsdon, CD, and Hwu, P. "Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma." Clinical cancer research : an official journal of the American Association for Cancer Research 17, no. 22 (November 2011): 7015-7023.

PMID
21976550
Full Text

Kaseb, AO, Morris, JS, Hassan, MM, Siddiqui, AM, Lin, E, Xiao, L, Abdalla, EK, Vauthey, J-N, Aloia, TA, Krishnan, S, and Abbruzzese, JL. "Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 29 (October 2011): 3892-3899.

PMID
21911725
Full Text

Carbone, C, Moccia, T, Zhu, C, Paradiso, G, Budillon, A, Chiao, PJ, Abbruzzese, JL, and Melisi, D. "Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype." Clinical cancer research : an official journal of the American Association for Cancer Research 17, no. 17 (September 2011): 5822-5832.

PMID
21737511
Full Text

Abbruzzese, JL. "Introducing CCR perspectives in drug approval." Clinical cancer research : an official journal of the American Association for Cancer Research 17, no. 15 (August 2011): 4929-.

PMID
21791634
Full Text

Melisi, D, Xia, Q, Paradiso, G, Ling, J, Moccia, T, Carbone, C, Budillon, A, Abbruzzese, JL, and Chiao, PJ. "Modulation of pancreatic cancer chemoresistance by inhibition of TAK1." Journal of the National Cancer Institute 103, no. 15 (August 2011): 1190-1204.

PMID
21743023
Full Text

El-Rayes, BF, Philip, PA, Sarkar, FH, Shields, AF, Ferris, AM, Hess, K, Kaseb, AO, Javle, MM, Varadhachary, GR, Wolff, RA, and Abbruzzese, JL. "A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer." Investigational new drugs 29, no. 4 (August 2011): 694-699.

PMID
20107864
Full Text

Crane, CH, Varadhachary, GR, Yordy, JS, Staerkel, GA, Javle, MM, Safran, H, Haque, W, Hobbs, BD, Krishnan, S, Fleming, JB, Das, P, Lee, JE, Abbruzzese, JL, and Wolff, RA. "Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 22 (August 2011): 3037-3043.

PMID
21709185
Full Text

Tanaka, M, Chang, P, Li, Y, Li, D, Overman, M, Maru, DM, Sethi, S, Phillips, J, Bland, GL, Abbruzzese, JL, and Eng, C. "Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer." Clinical cancer research : an official journal of the American Association for Cancer Research 17, no. 13 (July 2011): 4531-4540.

PMID
21551253
Full Text

Kaseb, AO, Hassan, MM, Lin, E, Xiao, L, Kumar, V, Pathak, P, Lozano, R, Rashid, A, Abbruzzese, JL, and Morris, JS. "V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials." Cancer 117, no. 11 (June 2011): 2478-2488.

PMID
24048796
Full Text

Varadhachary, GR, Spector, Y, Abbruzzese, JL, Rosenwald, S, Wang, H, Aharonov, R, Carlson, HR, Cohen, D, Karanth, S, Macinskas, J, Lenzi, R, Chajut, A, Edmonston, TB, and Raber, MN. "Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary." Clinical cancer research : an official journal of the American Association for Cancer Research 17, no. 12 (June 2011): 4063-4070.

PMID
21531815
Full Text

Pages